[HTML][HTML] Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer
H Azari, E Nazari, R Mohit, A Asadnia… - Scientific …, 2023 - ui.adsabs.harvard.edu
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer
H Azari, E Nazari, A Avan, R Mohit, M Maftooh… - Scientific …, 2023 - profdoc.um.ac.ir
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
[HTML][HTML] Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer
H Azari, E Nazari, R Mohit, A Asadnia, M Maftooh… - Scientific …, 2023 - ncbi.nlm.nih.gov
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer.
H Azari, E Nazari, R Mohit, A Asadnia… - Scientific …, 2023 - search.ebscohost.com
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer.
H Azari, E Nazari, R Mohit, A Asadnia, M Maftooh… - Scientific …, 2023 - europepmc.org
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer
H Azari, E Nazari, R Mohit, A Asadnia… - Scientific …, 2023 - pubmed.ncbi.nlm.nih.gov
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
[PDF][PDF] Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer
H Azari, E Nazari, R Mohit, A Asadnia… - Scientific …, 2023 - researchgate.net
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
[引用][C] Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer
H Azari, E Nazari, R Mohit, A Asadnia, M Maftooh… - Scientific …, 2023 - europepmc.org
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …
Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer
M Nassiri - Scientific Reports, 2023 - profdoc.um.ac.ir
Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …
even with the use of combination therapies. Recently, mounting evidence indicates the …